Floatz logo

IDETREXED

High Grade Serous Ovarian Cancer

Institute of Cancer Research, United KingdomSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the High Grade Serous Ovarian Cancer cohort.

Asset / SponsorPhaseRating
Veliparib
AbbVie
Phase 2BB
Upifitamab Rilsodotin
Mersana Therapeutics
Phase 3B
Avutometinib
University of Oklahoma
Phase 2CCC
Defactinib
University of Oklahoma
Phase 2CCC
Vinorelbine
AbbVie
Phase 1CCC

View all 11 →

Same molecule, other indications

IDETREXED is also rated in:

Solid TumoursDormant
CC
Indicative ·
44 / 100
View asset →
Multiple MyelomaDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →